BioMedica Diagnostics Passes Annual ISO Quality Audit

BioMedica Diagnostics is proud to announce its successful completion of the annual ISO quality audit, reaffirming its ability to continue operating in the highly regulated medical device industry. Despite a workforce of just 30, BioMedica meets the same rigorous international standards as larger scientific organizations with up to 300,000 employees.

Operating across 60 nations and six continents, BioMedica adheres to stringent quality requirements set by each country’s Ministry of Health. The company currently holds three prestigious certifications—ISO 13485, ISO 13485 MDSAP, and IVDR—each reflecting its commitment to meeting demanding global regulatory standards.

This achievement underscores BioMedica’s dedication to excellence and quality in an industry where compliance is non-negotiable.

Related News

Stay updated with the latest news and developments from across the Scotia Investments Family of Companies.

CKF Receives ACOA Support to Advance AI and Digital Transformation
04Mar

CKF Receives ACOA Support to Advance…

CKF Inc. was recently included in an announcement by…

Scotia Investments’ President and CEO Guest Speaks at University of Ottawa Leadership Program
05Feb

Scotia Investments’ President and CEO Guest…

Scotia Investments' President & CEO Randy MacMillan guest speaks…

Scotia Investments Supports Feed Nova Scotia During the Holiday Season
20Dec

Scotia Investments Supports Feed Nova Scotia…

SIL team supports Feed Nova Scotia during the holiday…